Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe von Mounteney, Jane, Giraudon, Isabelle, Denissov, Gleb, Griffiths, Paul

Volltext

Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future von Griffiths, Paul N., Seyler, Thomas, De Morais, Joanna M., Mounteney, Jane E., Sedefov, Roumen S.

Volltext

Impact of COVID-19 on drug markets, use, harms and drug services in Europe von Pirona, Alessandro, Matias, João, Montanari, Linda, Škařupová, Kateřina, Ferri, Marica, Giraudon, Isabelle, Mounteney, Jane, Sleiman, Sandrine, Natoniewska, Katarzyna, Guarita, Bruno, Vandam, Liesbeth, Surmont, Tim, Griffiths, Paul

Volltext

Earlier warning: A multi-indicator approach to monitoring trends in the illicit use of medicines von Mounteney, Jane, Haugland, Siren

Volltext

The same fundamental drivers but differently expressed: what can we learn from comparing the recent experiences with synthetic opioids in the US and Europe? von Griffiths, Paul, Mounteney, Jane, Sedefov, Roumen

Volltext

Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion? von Hughes, Brendan, Vandam, Liesbeth, Mounteney, Jane, Griffiths, Paul

Volltext

The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015 von Mounteney, Jane, Griffiths, Paul, Sedefov, Roumen, Noor, Andre, Vicente, Julián, Simon, Roland

Volltext

Is Europe facing an opioid epidemic: What does European monitoring data tell us? von Seyler, Thomas, Giraudon, Isabelle, Noor, André, Mounteney, Jane, Griffiths, Paul

Volltext

Trends in MDMA‐related mortality across four countries von Roxburgh, Amanda, Sam, Bulent, Kriikku, Pirkko, Mounteney, Jane, Castanera, Antonio, Dias, Mario, Giraudon, Isabelle

Volltext

Reducing drug related mortality in Europe - a seemingly intractable public health issue von Giraudon, Isabelle, Vicente, Julian, Matias, João, Mounteney, Jane, Griffiths, Paul

Volltext

Looking to the future—more concern than optimism that cryptomarkets will reduce drug‐related harms von Mounteney, Jane, Cunningham, Andrew, Groshkova, Teodora, Sedefov, Roumen, Griffiths, Paul

Volltext

Key Interpretation Challenges for Wastewater-Based Epidemiology of Illicit Drugs: A Norwegian Three-City Case Study von Bretteville-Jensen, Anne Line, Amundsen, Ellen Johanna, Mounteney, Jane

Volltext

Understanding changes in heroin availability in Europe over time: emerging evidence for a slide, a squeeze and a shock von GRIFFITHS, PAUL, MOUNTENEY, JANE, LANIEL, LAURENT

Volltext

The Experience of the Treatment Demand Indicator in Europe: A Common Monitoring Tool Across 30 Countries von Montanari, Linda, Pirona, Alessandro, Guarita, Bruno, Hedrich, Dagmar, Mounteney, Jane, Vicente, Julian

Volltext

Fentanils: a serious threat to public health von Mounteney, Jane, Griffiths, Paul, Sedefov, Roumen, Evans‐Brown, Michael

Volltext

Increasing complexity in European drug use: Highlights from the EMCDDA's 2014 European drug report von Mounteney, Jane, Griffiths, Paul

Volltext

Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon? von Montanari, Linda, Guarita, Bruno, Mounteney, Jane, Zipfel, Nina, Simon, Roland

Volltext

The Double Effect of COVID-19 Confinement Measures and Economic Recession on High-Risk Drug Users and Drug Services von Costa Storti, Claudia, Bretteville-Jensen, Anne Line, De Grauwe, Paul, Moeller, Kim, Mounteney, Jane, Stevens, Alex

Volltext

Nine reasons why ecstasy is not quite what it used to be von Mounteney, Jane, Griffiths, Paul, Bo, Alessandra, Cunningham, Andrew, Matias, Joao, Pirona, Alessandro

Volltext

Key Interpretation Challenges for Wastewater-Based Epidemiology of Illicit Drugs: A Norwegian Three-City Case Study von Bretteville-Jensen, Anne Line, Amundsen, Ellen J., Mounteney, Jane

Volltext